As of 2024-12-15, the Relative Valuation of Clearpoint Neuro Inc (CLPT) is (24.43) USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.33 USD, the upside of Clearpoint Neuro Inc based on Relative Valuation is -259.4%.
The range of the Relative Valuation is (24.35) - (25.88) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 37.0x - 41.3x | 38.8x |
| Forward P/E multiples | 32.4x - 39.3x | 35.4x |
| Fair Price | (24.35) - (25.88) | (24.43) |
| Upside | -258.9% - -268.9% | -259.4% |
| Date | P/E |
| 2024-12-13 | -23.29 |
| 2024-12-12 | -24.92 |
| 2024-12-11 | -24.97 |
| 2024-12-10 | -25.35 |
| 2024-12-09 | -22.28 |
| 2024-12-06 | -20.49 |
| 2024-12-05 | -19.18 |
| 2024-12-04 | -19.33 |
| 2024-12-03 | -18.24 |
| 2024-12-02 | -18.60 |
| 2024-11-29 | -18.80 |
| 2024-11-27 | -18.40 |
| 2024-11-26 | -18.18 |
| 2024-11-25 | -17.74 |
| 2024-11-22 | -17.99 |
| 2024-11-21 | -16.85 |
| 2024-11-20 | -16.66 |
| 2024-11-19 | -16.67 |
| 2024-11-18 | -16.32 |
| 2024-11-15 | -16.61 |
| 2024-11-14 | -17.08 |
| 2024-11-13 | -16.64 |
| 2024-11-12 | -16.90 |
| 2024-11-11 | -17.34 |
| 2024-11-08 | -17.71 |
| 2024-11-07 | -20.40 |
| 2024-11-06 | -20.34 |
| 2024-11-05 | -19.48 |
| 2024-11-04 | -19.36 |
| 2024-11-01 | -19.59 |
| 2024-10-31 | -18.83 |
| 2024-10-30 | -19.54 |
| 2024-10-29 | -19.79 |
| 2024-10-28 | -19.99 |
| 2024-10-25 | -19.82 |
| 2024-10-24 | -19.12 |
| 2024-10-23 | -18.68 |
| 2024-10-22 | -19.44 |
| 2024-10-21 | -20.11 |
| 2024-10-18 | -20.46 |
| 2024-10-17 | -18.33 |
| 2024-10-16 | -18.21 |
| 2024-10-15 | -18.30 |
| 2024-10-14 | -18.86 |
| 2024-10-11 | -17.64 |
| 2024-10-10 | -17.31 |
| 2024-10-09 | -18.44 |
| 2024-10-08 | -17.66 |
| 2024-10-07 | -16.41 |
| 2024-10-04 | -17.04 |